Heartworm disease – Overview, intervention, and industry perspective
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Dirofilaria immitis, also known as heartworm, is a major parasitic threat for dogs and cats around the world. Because of its impact on the health and welfare of companion animals, heartworm disease is of huge veterinary and economic importance especially in North America, Europe, Asia and Australia. Within the animal health market many different heartworm preventive products are available, all of which contain active components of the same drug class, the macrocyclic lactones. In addition to compliance issues, such as under-dosing or irregular treatment intervals, the occurrence of drug-resistant heartworms within the populations in the Mississippi River areas adds to the failure of preventive treatments. The objective of this review is to provide an overview of the disease, summarize the current disease control measures and highlight potential new avenues and best practices for treatment and prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · cited 1×
“The further advancement of the ‘omics’, and together with the rise of deep data analyses in multiple fields and other technologically advanced tools like mRNA or microRNA technologies (Britton et al., 2014; Sahin et al., 2014; Kis et al., 2019; Tombácz et al., 2021), may”
BackgroundThe FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104787 · Cited by 2,179
Precision medicine, AI, and the future of personalized health care
Johnson, K. B., Wei, W., Weeraratne, D., Frisse, M. E., Misulis, K., Rhee, K., Zhao, J., & Snowdon, J. L. (2021) · Clinical and Translational Science · doi:10.1111/cts.12884 · Cited by 1,854 · cited 1×
“Technology advancements of the life sciences in the last three decades have been so innovative that personalized or precision human medicine is possible today (Selzer et al., 2018; Johnson et al., 2020).”
BackgroundHuman and animal dirofilariasis: The emergence of a zoonotic mosaic
Simón, F., Siles-Lucas, M., Morchón, R., González-Miguel, J., Mellado, I., Carretón, E., & Montoya-Alonso, J. A. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00012-12 · Cited by 834
Bowman, D. D., Hendrix, C. M., Lindsay, D. S., & Barr, S. C. (2002) · doi:10.1002/9780470376805 · Cited by 638
Chapter 4 Heartworm Disease in Animals and Humans
McCall, J. W., Genchi, C., Kramer, L. H., Guerrero, J., & Venco, L. (2008) · Advances in Parasitology · doi:10.1016/s0065-308x(08)00204-2 · Cited by 609
Self-amplifying RNA vaccines for infectious diseases
Bloom, K., van den Berg, F., & Arbuthnot, P. (2021) · Gene Therapy · doi:10.1038/s41434-020-00204-y · Cited by 487 · cited 1×
“Current successful examples for an RNA-based vaccine approach are seen with the RNA vaccine candidates for global SARS-CoV-2 pandemic (Bloom et al., 2020).”
BackgroundMoxidectin and the avermectins: Consanguinity but not identity
Prichard, R., Ménez, C., & Lespine, A. (2012) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2012.04.001 · Cited by 439 · cited 8×
“(Prichard et al., 2012; Prichard and Geary, 2019).”
BackgroundInfluentialShrinking the malaria map: progress and prospects
Feachem, R. G., Phillips, A. A., Hwang, J., Cotter, C., Wielgosz, B., Greenwood, B. M., Sabot, O., Rodriguez, M. H., Abeyasinghe, R. R., Ghebreyesus, T. A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61270-6 · Cited by 429 · cited 1×
“Efforts to eliminate malaria in Europe and the Mediterranean date back as far as the late 19th century with a widespread achievement of elimination in the 20th century (Feachem et al., 2010).”
Heartworm Biology, Treatment, and Control
Bowman, D. D., & Atkins, C. E. (2009) · Veterinary Clinics of North America: Small Animal Practice · doi:10.1016/j.cvsm.2009.06.003 · Cited by 298 · cited 6×
“prolonged regimen of drug treatment, exercise restriction and sometimes even surgery (Bowman and Atkins, 2009; Carretón et al., 2019).”
BackgroundInfluential
Cited by
Expansion of canine heartworm in Spain
Montoya-Alonso, J. A., Morchón, R., García-Rodríguez, S. N., Falcón-Cordón, Y., Costa-Rodríguez, N., Matos, J. I., Rodríguez Escolar, I., & Carretón, E. (2022) · Animals · doi:10.3390/ani12101268 · Cited by 35
Current state of canine heartworm in Portugal
Esteves-Guimarães, J., Matos, J. I., Leal-Sousa, B., Oliveira, P., Lobo, L., Silvestre-Ferreira, A. C., Soares, C. S., Rodríguez-Escolar, I., Carretón, E., Morchón, R., et al. (2024) · Animals · doi:10.3390/ani14091300 · Cited by 11
Simultaneous Exposure to Angiostrongylus vasorum and Vector-Borne Pathogens in Dogs from Italy
Morelli, S., Gori, F., Colombo, M., Traversa, D., Sarrocco, G., Simonato, G., Nespeca, C., Di Cesare, A., Frangipane di Regalbono, A., Veronesi, F., et al. (2021) · Pathogens · doi:10.3390/pathogens10091200 · Cited by 11
Rodríguez-Escolar, I., Balmori-de la Puente, A., Infante González-Mohino, E., Collado-Cuadrado, M., Carretón, E., Montoya-Alonso, J. A., & Morchón, R. (2025) · Parasites & Vectors · doi:10.1186/s13071-025-07148-5 · Cited by 9
“Other hosts such as domestic cats, ferrets, and wild carnivores may also be affected [1, 2], while humans are considered accidental hosts [3, 4].”
Genchi, M., Venco, L., Melideo, O., Kramer, L., Fozzer, M., & Vismarra, A. (2025) · Parasites & Vectors · doi:10.1186/s13071-025-07059-5 · Cited by 7
Metadata
- Authors
- Noack, S., Harrington, J., Carithers, D. S., Kaminsky, R., & Selzer, P. M.
- Venue
- International Journal for Parasitology: Drugs and Drug Resistance
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 16
- Pages
- 65-89
- ISSN
- 2211-3207 (ISSN-L)
- OpenAlex
- W3159475034
- Cited by
- 121
- References
- 49
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heartworm disease – Overview, intervention, and industry perspective. https://app.cochat.ai/papers/10.1016/j.ijpddr.2021.03.004
- The paper
- Noack, S., Harrington, J., Carithers, D. S., Kaminsky, R., & Selzer, P. M. (2021). Heartworm disease – Overview, intervention, and industry perspective. International Journal for Parasitology: Drugs and Drug Resistance. https://doi.org/10.1016/j.ijpddr.2021.03.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.